Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Study drug QTX3034 for patients with KRAS G12D solid tumors (QTX3034-001)
Clinical Trial Grant
Duke Scholars
Principal Investigator
John Strickler
Medicine, Medical Oncology
Awarded By
Quanta Therapeutics, Inc.
Start Date
April 16, 2024
End Date
May 19, 2029
Awarded By
Quanta Therapeutics, Inc.
Start Date
April 16, 2024
End Date
May 19, 2029
